TH Theratechnologies Inc.

Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019

Theratechnologies to Announce Financial Results for Fourth Quarter and Fiscal Year 2019

MONTREAL, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the fourth quarter and fiscal year ended November 30, 2019, on Tuesday, February 25, 2020.

A conference call will be held on February 25, 2020 at 8:30 a.m. (ET) to discuss the results. The call will be hosted by Luc Tanguay, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a “listen-only” basis.

The conference call can be accessed by dialling 1-877-223-4471 (North America) or 1-647-788-4922 (International). The conference call will also be accessible via webcast at . Audio replay of the conference call will be available on the same day starting at 12:00 p.m. (ET) until March 10, 2020, by dialling 1-800-585-8367 (North America) or 1-416-621-4642 (International) and by entering the playback code 5896409.



INFORMATION:

Contact : Denis Boucher

Phone : 514.336.7800

EN
18/02/2020

Underlying

THTheratechnologies Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Theratechnologies Inc.

 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Announces Completion of Acquisition by Future Pak

Theratechnologies Announces Completion of Acquisition by Future Pak MONTREAL, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today the completion of the previously-announced plan of arrangement under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), pursuant to which the Purchaser has acquired all the issued and outstanding common shares of the...

September 25, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies annonce la réalisation de l’acquisition par Future P...

Theratechnologies annonce la réalisation de l’acquisition par Future Pak MONTRÉAL, 25 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, a annoncé aujourd’hui la réalisation du plan d’arrangement pris en vertu du chapitre XVI – section II de la Loi sur les sociétés par actions (Québec) annoncé précédemment et auquel est partie CB Biotechnology, LLC (l’« Acquéreur »), un membre du même groupe que Future Pak, LLC (« Future Pak »), aux termes duquel l’Acqué...

September 25, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies reçoit l’approbation définitive du tribunal relative...

Theratechnologies reçoit l’approbation définitive du tribunal relativement au plan d’arrangement proposé visant son acquisition par Future Pak MONTRÉAL, 16 sept. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade de la commercialisation, a annoncé aujourd’hui que la Société a obtenu l’ordonnance définitive de la Cour supérieure du Québec (chambre commerciale) approuvant le plan d’arrangement (l’« Arrangement ») pris en vertu du chapitre XVI – section II de la Loi sur les sociétés par ...

September 16, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Receives Final Court Approval of Proposed Plan of Ar...

Theratechnologies Receives Final Court Approval of Proposed Plan of Arrangement to Be Acquired by Future Pak MONTREAL, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, announced today that the Company has obtained the final order from the Superior Court of Québec (Commercial Division) approving the previously-announced plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Pu...

September 16, 2025 1 EN
 PRESS RELEASE
Free
TH Theratechnologi...

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to...

Theratechnologies Shareholders Approve Proposed Plan of Arrangement to Be Acquired by Future Pak MONTREAL, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that its shareholders have approved the previously announced plan of arrangement (the “Arrangement”) under Chapter XVI – Division II of the Business Corporations Act (Québec) involving CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”). At the special meetin...

September 12, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch